Seqirus USA Inc., a global biotechnology company, has been awarded a multiple-award Federal Supply Schedule (FSS) contract V797D70074 by the U.S. Department of Veterans Affairs (VA) to provide a range of influenza vaccines and pharmaceuticals.
The contract, which is set under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, enables Seqirus to deliver a variety of influenza vaccine formulations and presentations, including multi-dose vials, pre-filled syringes, and specialized vaccines for different age groups. The company has received numerous delivery orders worth over $1 million from federal agencies such as the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, and Department of Justice to fulfill large-scale vaccine requirements across various health programs. Seqirus also holds several high-value Indefinite Delivery Contracts (IDCs) and Indefinite Delivery Indefinite Quantity (IDIQ) contracts with a total ceiling value exceeding $500 million to supply influenza vaccines to these agencies over multiple flu seasons. The contract does not utilize any set-aside designations, likely due to Seqirus's specialized expertise in influenza vaccine production and delivery.
Generated 8/29/24, 9:10 AM